Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin C studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 50% Improvement Relative Risk Vitamin C  Kyagambiddwa et al.  LATE TREATMENT Is late treatment with vitamin C beneficial for COVID-19? Retrospective 246 patients in Uganda (May 2020 - August 2022) Lower mortality with vitamin C (not stat. sig., p=0.062) c19early.org Kyagambiddwa et al., Infection and Dru.., May 2023 Favors vitamin C Favors control

Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A Retrospective Cohort Study

Kyagambiddwa et al., Infection and Drug Resistance, doi:10.2147/idr.s405256
May 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020
 
*, now known with p = 0.000000087 from 70 studies, recognized in 11 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Retrospective 246 severe COVID-19 patients in Uganda, showing lower mortality with vitamin C treatment, without statistical significance (p = 0.06).
This is the 62nd of 70 COVID-19 controlled studies for vitamin C, which collectively show efficacy with p=0.000000087 (1 in 11 million).
21 studies are RCTs, which show efficacy with p=0.0012.
Study covers zinc and vitamin C.
risk of death, 50.0% lower, HR 0.50, p = 0.06, adjusted per study, multivariable, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kyagambiddwa et al., 11 May 2023, retrospective, Uganda, peer-reviewed, mean age 39.0, 15 authors, study period May 2020 - August 2022. Contact: tonnykyagambiddwa97@gmail.com, enuwagira@must.ac.ug.
This PaperVitamin CAll
Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A Retrospective Cohort Study
Tonny Kyagambiddwa, Timothy Mwanje Kintu, Emmanuel Miiro, Franchesca Nabalamba, Gloria Suubi Asiimwe, Anne Marion Namutebi, Fardous C Abeya, Boniface A Lumori, Isaac Ijuka, Rose K Muhindo, Andrew Mutekanga, Richard Musinguzi, Francis Natuhwera, Joseph Ngonzi, Edwin Nuwagira
Infection and Drug Resistance, doi:10.2147/idr.s405256
Background: There is scarcity of data regarding young and middle-aged adults hospitalized with severe Corona Virus Disease 2019 (COVID-19) in Africa. In this study, we describe the clinical characteristics and 30-day survival among adults aged 18 to 49 years admitted with severe COVID-19 in Uganda. Methods: We reviewed treatment records of patients admitted with severe COVID-19 across five COVID-19 treatment units (CTU) in Uganda. We included individuals aged 18 to 49 years, who had a positive test or met the clinical criteria for COVID-19. We defined severe COVID-19 as having an oxygen saturation <94%, lung infiltrates >50% on imaging and presence of a co-morbidity that required admission in the CTU. Our main outcome was the 30-day survival from the time of admission. We used a Cox proportional hazards model to determine the factors associated with 30-day survival at a 5% level of significance. Results: Of the 246 patient files reviewed, 50.8% (n = 125) were male, the mean ± (standard deviation) age was 39 ± 8 years, majority presented with cough, 85.8% (n = 211) and median C-reactive protein (interquartile range) was 48 (47.5, 178.8) mg/L. The 30-day mortality was 23.9% (59/246). At admission, anemia (hazard ratio (HR): 3.00, 95% confidence interval (CI), 1.32-6.82; p = 0.009) and altered mental state (GCS <15) (HR: 6.89, 95% CI: 1.48-32.08, p = 0.014) were significant predictors of 30-day mortality. Conclusion: There was a high 30-day mortality among young and middle-aged adults with severe COVID-19 in Uganda. Early recognition and targeted management of anemia and altered consciousness are needed to improve clinical outcomes.
Abbreviations Ethics Approval and Informed Consent The study was approved by the Research Ethics Committee of Mbarara University of Science and Technology under reference number MUST-2022-435. The ethics committee waived the requirement for consent. Permission for access to medical records was granted by the necessary boards at respective hospitals. Study codes were used to ensure the anonymity of participants' data. Data generated from the study shall be used for research purposes only and shall be private and confidential at all times. All principles of data transfer and principles of protection of human research participants outlined in the Declaration of Helsinki were observed. Disclosure The authors declare that they have no competing interests.
References
Adebisi, Rabe, Lucero-Prisno, De, COVID-19 surveillance systems in 13 African countries, Health Promot Perspect, doi:10.34172/hpp.2021.49
Anjorin, Abioye, Asowata, Comorbidities and the COVID-19 pandemic dynamics in Africa, Trop Med Int Health TM IH, doi:10.1111/tmi.13504
Apiyo, Olum, Kabuye, Clinical characteristics and outcomes of patients hospitalized with COVID-19 at case hospital, Uganda, Interdiscip Perspect Infect Dis, doi:10.1155/2022/5477790
Assal, Hm, Magdy, Predictors of severity and mortality in COVID-19 patients, Egypt J Bronchol, doi:10.1186/s43168-022-00122-0
Baguma, Okot, Alema, Factors associated with mortality among the COVID-19 patients treated at Gulu Regional referral hospital: a retrospective study, Front Public Health, doi:10.3389/fpubh.2022.841906
Bergamaschi, Borrelli De Andreis, Aronico, Anemia in patients with Covid-19: pathogenesis and clinical significance, Clin Exp Med, doi:10.1007/s10238-020-00679-4
Bongomin, Fleischer, Olum, High mortality during the second wave of the coronavirus disease 2019 (COVID-19) pandemic in Uganda: experience from a National Referral COVID-19 treatment unit, Open Forum Infect Dis, doi:10.1093/ofid/ofab530
Chen, Hoiland, Stukas, Wellington, Sekhon, Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome, Eur Respir J, doi:10.1183/13993003.03006-2020
Chinnaswamy, Understanding the devastating second wave of COVID -19 pandemic in India, Am J Hum Biol, doi:10.1002/ajhb.23671
Core, R: a language and environment for statistical computing
Cunningham, Vaduganathan, Claggett, Clinical outcomes in young US adults hospitalized with COVID-19, JAMA Intern Med, doi:10.1001/jamainternmed.2020.5313
Dadras, Seyedalinaghi, Karimi, COVID-19 mortality and its predictors in the elderly: a systematic review, Health Sci Rep, doi:10.1002/hsr2.657
English, Cn, Uganda lacks medical oxygen as hospitals overwhelmed by COVID-19, Xinhua
Gupta, Garg, Sapra, Infection and Drug Resistance Dovepress
Herrera-Esposito, De, Campos, Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies, BMC Infect Dis, doi:10.1186/s12879-022-07262-0
Hu, Huang, Yin, The cytokine storm and COVID-19, Infection and Drug Resistance, doi:10.1002/jmv.26232
Jha, Tak, Gupta, Relationship of anemia with COVID-19 deaths: a retrospective cross-sectional study, J Anaesthesiol Clin Pharmacol, doi:10.4103/joacp.joacp_63_22
Kirenga, Muttamba, Kayongo, Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda, BMJ Open Respir Res, doi:10.1136/bmjresp-2020-000646
Migisha, Kwesiga, Mirembe, Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches -march, Glob Health, doi:10.1186/s12992-020-00643-7
Mvb| Nw| Cn|, Obesity studies highlight severe COVID outcomes, even in young adults, CIDRAP
Mwananyanda, Gill, Macleod, Covid-19 deaths in Africa: prospective systematic postmortem surveillance study, BMJ, doi:10.1136/bmj.n334
News-Medical, Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa
Oh, Skendelas, Macdonald, On-admission anemia predicts mortality in COVID-19 patients: a single center, retrospective cohort study, Am J Emerg Med, doi:10.1016/j.ajem.2021.03.083
Perazzo, Cardoso, Ribeiro, In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: a prospective multicenter study from Brazil, Lancet Reg Health Am, doi:10.1016/j.lana.2022.100244
Salyer, Maeda, Sembuche, The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study, Lancet, doi:10.1016/S0140-6736(21)00632-2
Sandoval, Nguyen, Vahidy, Graviss, Risk factors for severity of COVID-19 in hospital patients age 18-29 years, PLoS One, doi:10.1371/journal.pone.0255544
Snyman, Sanders, Ndung, COVID-19 in Africa: preexisting immunity and HIV, AIDS, doi:10.1097/QAD.0000000000003079
Springerlink, Altered mental status in COVID-19, doi:10.1007/s00415-021-10623-5
Springerlink, Disorders of consciousness in hospitalized patients with covid-19: the role of the systemic inflammatory response syndrome, doi:10.1007/s12028-021-01256-7
Starke, Reissig, Petereit-Haack, Schmauder, Nienhaus et al., The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis, BMJ Glob Health, doi:10.1136/bmjgh-2021-006434
Statsenko, Zahmi, Habuza, Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings, Front Cell Infect Microbiol, doi:10.3389/fcimb.2021.777070
Tabernero, Ruiz, España, COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences, Infection, doi:10.1007/s15010-021-01684-9
Tao, Xu, Chen, Anemia is associated with severe illness in COVID-19: a retrospective cohort study, J Med Virol, doi:10.1002/jmv.26444
Team, Uganda, one ICU Bed for 188,000 Ugandans. The Monitor; 2021
Van Son, Oussaada, Şekercan, Overweight and obesity are associated with acute kidney injury and acute respiratory distress syndrome, but not with increased mortality in hospitalized COVID-19 patients: a retrospective cohort study, Front Endocrinol, doi:10.3389/fendo.2021.747732
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, doi:10.1001/jama.2020.2648
Xiong, Lu, Zhang, Association of consciousness impairment and mortality in people with COVID-19, Acta Neurol Scand, doi:10.1111/ane.13471
Zhang, Wu, He, Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study, Front Med, doi:10.3389/fmed.2021.757459
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit